+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease



The mechanisms of NLRP3 inflammasome/pyroptosis activation and their role in Parkinson's disease



International Immunopharmacology 67: 458-464



Parkinson's disease (PD) is a typical neurodegenerative disease and the pathological feature of which is the death of dopamine neurons in the substantia nigra region. At present, neuronal death caused by inflammatory cytokine-mediated neuroinflammation is being extensively studied. The nucleotide-binding oligomerization domain-, leucine-rich repeat and pyrin domain-containing 3 (NLRP3) inflammasome is an inflammatory complex existing in microglia. Its activation promotes the secretion of the inflammatory cytokine interleukin-1β/18 (IL-1β/18) and induces pyroptosis, a type of cell death that possesses the potential for inflammation, to rupture microglia to further release IL-1β. In this review we focus on the mechanisms of activation of the NLRP3 inflammasome and pyroptosis and their inflammatory effects on the development of PD. In addition, we focus on some inhibitors of NLRP3 inflammatory pathways to alleviate the progression of PD by inhibiting central inflammation and provide new therapeutic strategies for the treatment of PD.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066046691

Download citation: RISBibTeXText

PMID: 30594776

DOI: 10.1016/j.intimp.2018.12.019


Related references

MicroRNA-135b alleviates MPP + -mediated Parkinson's disease in in vitro model through suppressing FoxO1-induced NLRP3 inflammasome and pyroptosis. Journal of Clinical Neuroscience 65: 125-133, 2019

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation and fibrosis. Hepatology, 2013

E2-Induced Activation of the NLRP3 Inflammasome Triggers Pyroptosis and Inhibits Autophagy in HCC Cells. Oncology Research 27(7): 827-834, 2019

Nlrp3 inflammasome activation and Gasdermin D-driven pyroptosis are immunopathogenic upon gastrointestinal norovirus infection. Plos Pathogens 15(4): E1007709, 2019

NLRP3 inflammasome activation results in hepatocyte pyroptosis, liver inflammation, and fibrosis in mice. Hepatology 59(3): 898-910, 2014

Mesoporous silica nanoparticles induced hepatotoxicity via NLRP3 inflammasome activation and caspase-1-dependent pyroptosis. Nanoscale 10(19): 9141-9152, 2018

CdSe/ZnS quantum dots induce hepatocyte pyroptosis and liver inflammation via NLRP3 inflammasome activation. Biomaterials 90: 27-39, 2016

In Barrett's Epithelial Cells, Lipopolysaccharide (Lps) Induces Tlr4 Signaling With Activation of the Nlrp3 Inflammasome, Pro-Inflammatory Cytokine Secretion and Pyroptosis: A Potential Role for the Esophageal Microbiome in Barrett's Carcinogenesis. Gastroenterology 148(4): S-100, 2015

NLRP3 Inflammasome Activation-Mediated Pyroptosis Aggravates Myocardial Ischemia/Reperfusion Injury in Diabetic Rats. Oxidative Medicine and Cellular Longevity 2017: 9743280, 2017

UFL1 modulates NLRP3 inflammasome activation and protects against pyroptosis in LPS-stimulated bovine mammary epithelial cells. Molecular Immunology 112: 1-9, 2019

Comparative effects of schisandrin A, B, and C on Propionibacterium acnes-induced, NLRP3 inflammasome activation-mediated IL-1β secretion and pyroptosis. Biomedicine and PharmacoTherapy 96: 129-136, 2017

Su1831 Activation of Adenosine A3 Receptor Inhibits Nlrp3 Inflammasome and Pyroptosis of Colonic Epithelial Cells of Patients with Ulcerative Colitis. Gastroenterology 156(6): S-627, 2019

Gut Microbial Products and Saturated Fatty Acids Lead to Nitrergic Enteric Neuronal Pyroptosis via Activation of Ros-Mediated Nek7/Nlrp3 Inflammasome Pathway. Gastroenterology 154(6): S-55-S-56, 2018

Bushen-Yizhi Formula Alleviates Neuroinflammation via Inhibiting NLRP3 Inflammasome Activation in a Mouse Model of Parkinson's Disease. Evidence-BasedComplementaryandAlternativeMedicine2018:3571604, 2018

New insights into mechanisms controlling the NLRP3 inflammasome and its role in lung disease. American Journal of Pathology 184(1): 42-54, 2014